| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/27/1994 | EP0607217A1 Pyridinol derivatives as medicaments |
| 07/27/1994 | CN1089951A Novel glycoforms of soluble complement receptor 1 |
| 07/27/1994 | CA2114178A1 5-membered heterocycles, processes for preparing them and pharmaceutical compositions containing these compounds |
| 07/26/1994 | USRE34672 Diuretics |
| 07/26/1994 | US5332746 8,9-annelated-β-carbolines and 8,9-annelated 3,4-dihydro-β-carbolines |
| 07/26/1994 | CA2114153A1 Antithrombin composition and process for preparation thereof |
| 07/26/1994 | CA2114152A1 Antithrombin composition and process for preparation thereof |
| 07/26/1994 | CA1330937C Hemoglobin multiple emulsion |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994015958A2 Peptide inhibitors of cell adhesion |
| 07/21/1994 | WO1994015913A1 Chemical compounds |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015631A1 Dry plasminogen preparation |
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | WO1994009625A3 Stabilization of fluorocarbon emulsions |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | CA2153228A1 Peptide inhibitors of cell adhesion |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0606376A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors |
| 07/20/1994 | EP0606332A1 Method of producing starch decomposition products with a narrow molecular-weight distribution |
| 07/20/1994 | CN1089603A Novel pyridine-2-carboxylase and pyridine-N-oxide and preparation and pharmaceutical use of same |
| 07/19/1994 | US5331014 Effect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/19/1994 | US5330907 Method of preparing activated protein C |
| 07/15/1994 | CA2381458A1 Process for constructing a cdna library and a novel polypeptide and dna coding the same |
| 07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |
| 07/13/1994 | EP0605690A1 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids |
| 07/13/1994 | EP0605462A1 New isosteric peptides |
| 07/12/1994 | US5328996 DNA as anticoagulants |
| 07/12/1994 | US5328992 Metal complexes of polyethylene glycol carbamate derivatives of desferrioxamine B |
| 07/12/1994 | US5328921 Antagonist of platelet activating factor |
| 07/12/1994 | US5328909 Cyclopropenone derivatives |
| 07/12/1994 | US5328901 Respiratory system disorders |
| 07/12/1994 | US5328694 Stable injectable solution of factor VIII |
| 07/12/1994 | US5328470 Catheter |
| 07/12/1994 | CA1330663C Thiazolidinedione derivatives |
| 07/07/1994 | WO1994014959A1 New protein from urine named component b |
| 07/07/1994 | WO1994014798A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors |
| 07/07/1994 | WO1994014776A2 Bicyclic fibrinogen antagonists |
| 07/07/1994 | WO1994014775A1 Platelet aggregation inhibiting compounds |
| 07/07/1994 | WO1994014468A1 Improved peritoneal dialysis solutions with polypeptides |
| 07/07/1994 | CA2152631A1 Bicyclic fibrinogen antagonists |
| 07/07/1994 | CA2151156A1 New protein from urine named component b |
| 07/07/1994 | CA2129991A1 Improved peritoneal dialysis solutions with polypeptides |
| 07/06/1994 | EP0605193A1 Use of benzothiophenes for treatment of hypercholesterolaemia |
| 07/06/1994 | EP0604800A1 4- 4- 4-(carboxyalkyl)-phenyl amino carbonyl -phenyl -piperedines as aggregation inhibitors |
| 07/06/1994 | EP0574510A4 Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors |
| 07/06/1994 | CN1025337C Process for preparing pyrrolo |2,1-b¨ thiazole derivatives |
| 07/05/1994 | US5326558 Megakaryocytopoietic factor |
| 07/05/1994 | CA1330562C Benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome |
| 06/29/1994 | EP0603769A1 Alpha-Aminoketone derivatives |
| 06/29/1994 | EP0603671A2 Process of reactivating purified membrane proteins |
| 06/29/1994 | EP0401303B1 Novel human tissue plasminogen activator variants and processes |
| 06/29/1994 | CN1088583A Phospholipi derivatives containing higher elements of the Vth main group |
| 06/28/1994 | US5324749 Pharmaceutical aqueous solution of 4-[2-(benzene-sulphonylamino)-ethyl]-phenoxyacetic acid |
| 06/28/1994 | US5324732 Crystalline fumaric acid salts of 9,9-alkylene-3,7-diazabicyclononane compounds and pharmaceutical compositions containing them |
| 06/28/1994 | US5324715 Protein for inhibiting collagen-stimulated platelet aggregation |
| 06/26/1994 | CA2111931A1 .alpha.-aminoketone derivatives |
| 06/24/1994 | CA2112192A1 Process for reactivating purified membrane proteins |
| 06/23/1994 | WO1994013807A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | WO1994013693A1 NOVEL INHIBITORS OF FACTOR Xa |
| 06/23/1994 | CA2151044A1 Novel inhibitors for factor xa |
| 06/23/1994 | CA2150909A1 Clotting inhibitor made from protostomia saliva |
| 06/23/1994 | CA2150033A1 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer |
| 06/22/1994 | EP0603112A1 Use of thrombin inhibitors for inhibiting ocular fibrin formation |
| 06/22/1994 | EP0602921A1 Bicarbonate dialysis dialysate component and method of manufacture |
| 06/22/1994 | EP0602619A1 Controlled-release pharmaceutical compositions containing nicergoline |
| 06/22/1994 | EP0602483A1 Diazepine derivatives |
| 06/22/1994 | EP0602173A1 Topical fibrinogen complex |
| 06/22/1994 | EP0602025A1 N-(1-(2-carboxyethyl)cycloalkyl carbonyl)-beta-alanine derivatives for pharmaceutical use |
| 06/22/1994 | EP0513072B1 Improved cyclodextrin based erythropoietin formulation |
| 06/22/1994 | CN1088095A Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer |
| 06/21/1994 | US5322926 Thrombin inhibitors |
| 06/21/1994 | US5322844 Cardiovascular disorders, antiinflammatory agents, antiallergens |
| 06/21/1994 | CA1330343C Biologically active compounds |
| 06/21/1994 | CA1330299C Composition of anticoagulants |
| 06/19/1994 | CA2110529A1 Diazepine derivatives |
| 06/18/1994 | CA2111644A1 Use of thrombin inhibitors for the inhibition of ocular fibrin formation |
| 06/16/1994 | DE4241632A1 New (aza)aromatic or alicyclic carboxylic acid cpds. - used e.g. for treating thrombosis, inflammation, osteoporosis, cardiac infarct or tumour metastasis |
| 06/15/1994 | EP0601459A2 Sulfonamido heterocyclic thrombin inhibitors |
| 06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
| 06/15/1994 | EP0601043A1 Hybrid cytokines |
| 06/15/1994 | EP0600928A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it |
| 06/15/1994 | CN1087904A Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/14/1994 | US5321133 Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same |
| 06/14/1994 | US5321041 Diphenylpyrrolylfuran derivatives |
| 06/14/1994 | US5321034 Fibrinogen receptor antagonists |
| 06/14/1994 | US5321010 Proteins for inhibiting adhesion of platelets to collagen |
| 06/11/1994 | CA2111035A1 Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/09/1994 | WO1994012639A2 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | WO1994012638A2 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
| 06/09/1994 | WO1994012478A1 Benzimidazole compounds which inhibit platelet aggregation |
| 06/09/1994 | WO1994012463A1 Nitric esters having a pharmacological activity and process for their preparation |
| 06/09/1994 | WO1994012208A1 Process for producing plasminogen-containing composition |
| 06/09/1994 | WO1994012181A1 Fibrinogen receptor antagonists |
| 06/09/1994 | CA2150550A1 Fibrinogen receptor antagonists |
| 06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |